Literature DB >> 11375260

Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat.

J McDaid1, J R Docherty.   

Abstract

We have investigated the effects of methylenedioxymethamphetamine (MDMA, 'ecstasy'), i.v., on diastolic blood pressure (DBP) in pithed and pentobarbitone anaesthetized rats. In pithed rats, the non-selective 5-HT receptor antagonist methiothepin (0.1 mg kg(-1)) and the alpha2-adrenoceptor antagonists methoxyidazoxan and yohimbine (1 mg kg(-1)) showed significant alpha1-adrenoceptor antagonist potency, but methiothepin did not show alpha2-adrenoceptor antagonist potency. MDMA (1 and 5 mg kg(-1)) produced pressor responses which were significantly reduced by the alpha(1)-adrenoceptor antagonist prazosin (0.1 mg kg(-1)), yohimbine (1 mg kg(-1)) or methiothepin (0.1 mg kg(-1)), but not by the 5-HT2 receptor antagonist ritanserin (1 mg kg(-1)). In anaesthetized rats, antagonists revealed two phases with three components to the effects of MDMA (5 mg kg(-1)) on DBP: an initial pressor response, a later pressor component at 1 min, the sustained depressor response. Methoxyidazoxan, methiothepin or the combination ritanserin/prazosin significantly reduced the initial pressor response, although neither of the latter compounds alone had any effect. The pressor response to MDMA (5 mg kg(-1)) at 1 min was converted to a depressor response by prazosin and to a lesser extent methiothepin and methoxyidazoxan. The depressor response to MDMA (5 mg kg(-1)) was significantly reduced by methoxyidazoxan (0.1 mg kg(-1)), and by the noradrenaline re-uptake blocker cocaine 10 mg kg(-1) but not 1 mg kg(-1). However, the most marked reduction in the depressor response was produced by the combination of methoxyidazoxan and cocaine. It is concluded that the initial pressor response to MDMA (5 mg kg(-1)) in anaesthetized rats involves alpha2- and possibly alpha1-adrenoceptors and 5-HT2 receptors, the pressor component at 1 min is largely alpha1-adrenoceptor mediated, and the sustained depressor response involves alpha2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375260      PMCID: PMC1572800          DOI: 10.1038/sj.bjp.0704094

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Investigation of the prejunctional alpha2-adrenoceptor mediated actions of MDMA in rat atrium and vas deferens.

Authors:  A Lavelle; V Honner; J R Docherty
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  5-HT1-like receptors: a time to bid goodbye.

Authors:  P R Saxena; P De Vries; C M Villalón
Journal:  Trends Pharmacol Sci       Date:  1998-08       Impact factor: 14.819

3.  Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.

Authors:  N E Andén; M Grabowska; U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

4.  Involvement of central alpha 2-adrenoceptors in the mediation of clonidine-induced hypotension in the cat.

Authors:  T C Hamilton; A A Hunt; R H Poyser
Journal:  J Pharm Pharmacol       Date:  1980-11       Impact factor: 3.765

5.  A comparison of pre- and post-junctional potencies of several alpha-adrenoceptor agonists in the cardiovascular system and anococcygeus muscle of the rat. Evidence for two types of post-junctional alpha-adrenoceptor.

Authors:  J R Docherty; J C McGrath
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

6.  The psychological and physiological effects of MDMA on normal volunteers.

Authors:  J Downing
Journal:  J Psychoactive Drugs       Date:  1986 Oct-Dec

7.  MDMA. The dark side of ecstasy.

Authors:  G N Hayner; H McKinney
Journal:  J Psychoactive Drugs       Date:  1986 Oct-Dec

8.  Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine.

Authors:  P B Bradley; G Engel; W Feniuk; J R Fozard; P P Humphrey; D N Middlemiss; E J Mylecharane; B P Richardson; P R Saxena
Journal:  Neuropharmacology       Date:  1986-06       Impact factor: 5.250

9.  The physiological and pharmacological role of presynaptic alpha- and beta-adrenoceptors in man.

Authors:  M J Brown; A D Struthers; J M Burrin; L Di Silvio; D C Brown
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

10.  'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA.

Authors:  G P Dowling; E T McDonough; R O Bost
Journal:  JAMA       Date:  1987-03-27       Impact factor: 56.272

View more
  13 in total

Review 1.  Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA).

Authors:  J R Docherty
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

Review 2.  The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives.

Authors:  J R Docherty; A R Green
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

3.  In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA.

Authors:  D M Cannon; A K Keenan; P J Guiry; C Buon; A W Baird; G J McBean
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

Review 4.  The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine.

Authors:  Edward M Mills; Daniel E Rusyniak; Jon E Sprague
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

5.  Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.

Authors:  Charles W Schindler; Eric B Thorndike; Bruce E Blough; Srihari R Tella; Steven R Goldberg; Michael H Baumann
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

6.  Role of alpha1-adrenoceptor subtypes in the effects of methylenedioxy methamphetamine (MDMA) on body temperature in the mouse.

Authors:  S Bexis; J R Docherty
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

7.  Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involve alpha-adrenoceptors.

Authors:  Sotiria Bexis; James R Docherty
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

8.  Role of alpha 1- and beta 3-adrenoceptors in the modulation by SR59230A of the effects of MDMA on body temperature in the mouse.

Authors:  Sotiria Bexis; James R Docherty
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

9.  Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice.

Authors:  William E Fantegrossi; Christina Lynn Kiessel; P Tarn Leach; C Van Martin; Rachel Lynn Karabenick; X Chen; Y Ohizumi; Thomas Ullrich; Kenner C Rice; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2004-01-22       Impact factor: 4.530

10.  Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists.

Authors:  Jon E Sprague; Robert E Brutcher; Edward M Mills; David Caden; Daniel E Rusyniak
Journal:  Br J Pharmacol       Date:  2004-05-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.